Perspectives on Aducanumab Approval (Neurology Recall August 2021)
Release Date: 08/01/2021
Corticosteroids in LGI1 Antibody Encephalitis
Neurology® Podcast
Dr. Justin Abbatemarco talks with Prof. Sarosh Irani about the use of corticosteroids as a first-line agent in the treatment of LGI1 antibody encephalitis.
info_outline
NINDS Mission and Clinical Neurology with Walter Koroshetz
Neurology® Podcast
Dr. Gregg Day talks with Dr. Walter Koroshetz, Director of the National Institute of Neurological Disorders and Stroke, about NINDS's mission and clinical neurology.
info_outline
Medicare Limitation of Aduhelm
Neurology® Podcast
Dr. Jeff Burns talks with Dr. Ron Petersen, Director of the Mayo Clinic Alzheimer's Disease Research Center, about Medicare's recent decision to officially limit Aduhelm (aducanumab) coverage to patients in clinical trials. Read the .
info_outline
EEG Patterns and Neurofilament Light After Cardiac Arrest
Neurology® Podcast
Dr. Karen Hirsch talks with Dr. Linnéa Grindegård about the association between EEG patterns and serum neurofilament light as a marker of neuroaxonal injury after cardiac arrest. Read the .
info_outline
Race-Ethnic Disparities in Stroke Thrombolysis
Neurology® Podcast
Drs. B.J. Hicks and Andy Southerland talk with Dr. Scott Mendelson about racial and ethnic disparities in the rates of declination of thrombolysis in patients with acute ischemic stroke. Read the .
info_outline
A Review of L-arginine in MELAS
Neurology® Podcast
Dr. Justin Abbatemarco talks with Prof. Gráinne Gorman about the use of L-arginine in the treatment of mitochondrial encephalopathy, lactic acidosis, and strokelike episodes (MELAS). Read the .
info_outline
Pure Sleep Epilepsy in Patients With First Seizure
Neurology® Podcast
Dr. Fábio Nascimento talks with Dr. Elaine Pang about the identification and characterization of pure sleep epilepsy after first-ever seizures from sleep in adults. Read the .
info_outline
June 2022 Neurology Recall: Aducanumab's Approval, One Year Later
Neurology® Podcast
The June 2022 replay of past episodes showcases a selection of interviews about the impact of the FDA's approval of aducanumab for the treatment of Alzheimer disease (AD). This episode features illuminating conversations with Drs. Gregg Day, Ron Petersen, and Jason Karlawish on the clinical science guiding amyloid-based treatments for AD, the importance of patient participation when considering the use of aducanumab, and the business of Alzheimer disease, respectively. This month's Recall concludes with an interview featuring Pulitzer Prize-winning journalist Pam Belluck on Medicare's...
info_outline
Association of PD Symptoms With Quality of Life
Neurology® Podcast
Dr. Jeff Ratliff talks with Dr. Meredith Bock about the association of motor, non-motor, and behavioral symptoms with health-related quality of life in people with Parkinson disease. Read the .
info_outline
Neurodegeneration in Pro Football Players: TBI/CTE
Neurology® Podcast
In the second part of our two-part series on neurodegeneration in professional football players, Dr. Shuvro Roy talks with Dr. Ann McKee about her career and work studying the consequences of repetitive traumatic brain injury (TBI) and chronic traumatic encephalopathy (CTE). For more information on the VA-BU-CLF Brain Bank at the Boston University CTE Center, including brain donation inquiries, .
info_outlineThis month’s replay of past episodes showcases a selection of interviews concerning the FDA approval of aducanumab for the treatment of Alzheimer disease from clinical, political, and economic perspectives. The selected interviews feature conversations between Dr. Gregg Day and Pam Belluck, Dr. Jeff Burns and Dr. Ron Peterson, Dr. Jason Crowell and Dr. Steve Pearson, and Dr. Jeff Burns and Dr. Daniel Gibbs.